---
name: AvantGen, Inc.
slug: avantgen
site: cro
website_domain: avantgen.com
summary: AvantGen enables antibody discovery and optimization through proprietary yeast display platforms offering scFv, Fab, and VHH modalities with over 100 billion fully human antibody clones.
tagline: Premier partner in advancing antibody drugs through discovery and optimization.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-09-22T07:02:34.356Z
services_count: 2
modalities_count: 1
indications_count: 2
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# AvantGen, Inc.

Premier partner in advancing antibody drugs through discovery and optimization.

Listed on cro.directory.

## Summary

AvantGen enables antibody discovery and optimization through proprietary yeast display platforms offering scFv, Fab, and VHH modalities with over 100 billion fully human antibody clones.

## Services

- Discovery Research
- Protein Engineering

## Modalities

- Biologics (Monoclonal Antibodies)

## Indications

- Oncology
- Immunology

## Long description

## Antibody Discovery & Engineering

AvantGen is a contract research organization specializing in antibody discovery and optimization for scientific partners developing novel antibody drugs. The company operates through multiple proprietary platforms:

### Platforms

- **AvantEpee (scFv)**: Single-chain Fv antibodies optimized for stability and expression
- **AvantSabre (Fab)**: Fab-format antibodies for therapeutic development
- **AvantFoil (VHH)**: Small, highly stable VHH (nanobody) format
- **AvantGeneer**: Affinity maturation and lead candidate optimization, typically improving affinity 10- to 100-fold
- **AvantBunny**: Rabbit monoclonal antibody discovery for superior affinity and specificity in nonhuman reagent and diagnostic applications

### Technology

AvantGen's proprietary yeast display system utilizes an engineered anchoring peptide enabling efficient cell surface display and high inducible secretion without reducing agents. The **Germliner™ Library Collection** represents deep sequencing of over 500 individuals, yielding three fully human platforms with more than 100 billion antibody clones exhibiting high affinity, high specificity, high thermostability, high expression levels, and no or low immunogenicity.

### Services

The company provides discovery-stage antibody generation, affinity maturation, and optimization services. AvantGen handles antigen bioconjugation and quality control, accepting biotinylated, DyLight™ 650 conjugated, and unlabeled antigens meeting specified purity (>90%), monomer percentage (>80%), and concentration (>0.5 mg/mL) standards.

### Applications

Clients leverage AvantGen platforms for CAR-T development, cancer immunotherapy (including NK cell engager licensing), and other therapeutic modalities requiring stable, developable antibodies.

## Related companies

- [Accelagen, Inc.](/companies/accelagen) (Protein Engineering, Biologics (Monoclonal Antibodies)) — [Compare](/compare/accelagen/avantgen)
- [IPM Biotech](/companies/ipmbiotech) (Discovery Research, Protein Engineering) — [Compare](/compare/avantgen/ipmbiotech)
- [Nexus BioQuest](/companies/nexus-bioquest) (Discovery Research, Biologics (Monoclonal Antibodies)) — [Compare](/compare/avantgen/nexus-bioquest)
- [TRiCBIO](/companies/tricbio) (Discovery Research, Biologics (Monoclonal Antibodies)) — [Compare](/compare/avantgen/tricbio)
- [Cyagen Biosciences](/companies/apac-cyagen) (Discovery Research, Biologics (Monoclonal Antibodies)) — [Compare](/compare/apac-cyagen/avantgen)
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) (Discovery Research, Protein Engineering) — [Compare](/compare/aurigeneservices/avantgen)
- [ChemPartner](/companies/chempartner) (Discovery Research, Protein Engineering) — [Compare](/compare/avantgen/chempartner)
- [AAVATAR Therapeutics](/companies/en-aavatartps) (Discovery Research) — [Compare](/compare/avantgen/en-aavatartps)

_Profile last updated: 2026-09-22T07:02:34.356Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.